window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 30, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Clinical Research

  • Clinical Trials,Drug Development,Women in Pharma

    Fixing the gender gap in clinical trials

    Dr Anita Phung, GP and medical monitor at Lindus Health, [...]

    May 20, 2025
  • Movers & Shakers

    Ed Seguine appointed CEO of Target RWE

    May 6, 2025
  • Artificial Intelligence

    Indegene outlines critical GenAI lessons and strategies for the future of life sciences

    April 28, 2025
  • Artificial Intelligence,Clinical Trials

    Lokavant launches AI-powered forecasting tool to cut clinical trial planning time from weeks to minutes

    April 25, 2025
  • Regulatory Affairs

    Real time site activation visibility: Advarra integrates CIRBI IRB with study collaboration

    April 24, 2025
  • Clinical Trials

    Teckro launches patient data return feature to enhance transparency and engagement in clinical trials

    April 22, 2025
Previous12

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Neomorph raises $100 million to advance NEO-811 Phase 1/2 cancer trial and molecular glue degrader pipeline
    Categories: Biotech, Clinical Trials, Drug discovery, Funding, Oncology, Partnerships & Funding, Pharmaceuticals and therapeutics, Research & Development, Technology and platforms
  • NICE expands Lokelma access for hyperkalaemia after draft recommendation
    Categories: Cardiovascular diseases, Chronic diseases, Market Access & Commercialization, Pharmaceuticals and therapeutics, Regulatory Affairs
  • Oncodesign expands ARRONAX deal to secure astatine-211 supply for radiotherapy research
    Categories: CDMOs & Manufacturing, Drug Development, European biotech, Logistics and distribution, Oncology, Partnerships & Funding, Supply Chain & Logistics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top